Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2000
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000028013A3 Gene expression modulated by activation of microglia or macrophages
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000027423A3 Methods and compositions for treating common cold symptoms
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000024938A3 CCG REPEATS IN cDNAs FROM HUMAN BRAIN
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000022169A9 DETECTION USING Snz AND Sno GENES AND PROTEINS
11/23/2000WO2000022093A3 Novel interferon stimulated and repressed genes
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000016098A9 Composite devices incorporating biological material and methods
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/23/2000WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders
11/23/2000DE19923568A1 Incorporating gcpE and yfgB genes into viruses and cells, for increasing isoprenoid content and identifying e.g. antimicrobial agents, comprises using DNA sequences from bacteria or parasites
11/23/2000DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers
11/23/2000DE19919982A1 Verfahren zur Ermittlung osteoporotischer Prozesse Procedure for the determination of osteoporotic processes
11/23/2000DE19919634A1 Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer NBD-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen Test to determine the integrity of complex phospholipid / lipid structures using synthetic NBD-labeled acylglycerides and its application to determination of the activity of lipases
11/23/2000CA2376722A1 Chloramphenicol biosynthetic pathway and gene cluster characterization
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372851A1 Device and method for monitoring and controlling biologically active fluids
11/23/2000CA2372783A1 Identifying material from a breast duct
11/23/2000CA2372761A1 Methods for predicting and/or diagnosing the risk of gastric cancer
11/23/2000CA2372667A1 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
11/23/2000CA2372661A1 Cdx2 is downstream mediator of apc tumor suppressor activity
11/23/2000CA2372654A1 Acquired resistance genes in plants
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000CA2372294A1 Genetic marker for meat quality, growth, carcass and reproductive traits in livestock
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2372036A1 Compositions of solvents and high concentrations of nucleic acid analogs
11/23/2000CA2371245A1 Crystal structure of ribosomal protein l11/gtpase activating region rrna and uses thereof
11/23/2000CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/23/2000CA2368624A1 Novel .beta.-secretase and modulation of .beta.-secretase activity
11/22/2000EP1054259A1 Method for the identification of a target compound
11/22/2000EP1054258A1 Homogeneous enzyme immunoassay process using second antibody
11/22/2000EP1054066A2 Method for anticipating sensitivity to medicine for osteoporosis and a reagent therefor
11/22/2000EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation
11/22/2000EP1054056A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically
11/22/2000EP1054055A1 Method for providing a substrate structure for oriented neuron growth, substrate structure, and device for monitoring neurons
11/22/2000EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents
11/22/2000EP1053474A1 Method for the determination of prosthetic infections
11/22/2000EP1053460A2 An automatic method of classifying molecules
11/22/2000EP1053357A1 Processes for isolating, amplifying and characterizing dna
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1053355A2 Pna and dna conjugates and methods for preparation thereof
11/22/2000EP1053354A1 Direct detection of rna mediated by reverse transcriptase lacking rnase h function
11/22/2000EP1053353A1 Eluting reagents, methods and kits for isolating dna
11/22/2000EP1053352A1 Mismatch detection techniques
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053350A1 Methods for dna amplification and sequencing
11/22/2000EP1053349A1 Methods for identifying therapeutic targets
11/22/2000EP1053348A2 Determination of a genotype of an amplification product at multiple allelic sites
11/22/2000EP1053346A1 Biosensor for pentachlorophenol
11/22/2000EP1053345A1 Method for producing baccatin
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/22/2000EP1053334A1 Plant alkaline and neutral invertases
11/22/2000EP1053332A1 Protein
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053319A2 Human genes and gene expression products ii
11/22/2000EP1053318A2 Cdnas encoding secreted proteins
11/22/2000EP1053317A1 Use of ribozymes for functionating genes
11/22/2000EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053311A2 Compositions and methods for using a lysing matrix for isolating dna
11/22/2000EP1053309A1 Compositions and methods for wound healing
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053306A1 Secreted proteins and polynucleotides encoding them
11/22/2000EP1053305A1 SUBSTRATE ANALOGS FOR MurG, METHODS OF MAKING SAME AND ASSAYS USING SAME
11/22/2000EP1053298A1 Integrated microfluidic devices
11/22/2000EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053237A2 Inhibition of human telomerase by a g-quadruplex-interaction compound
11/22/2000EP1053055A1 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1045923A4 Method for isolation and identification of (escherichia coli) 0157:h7 and plating media for said process
11/22/2000EP1008098A4 Method for remote sensing analysis by decorrelation statistical analysis and hardware therefor
11/22/2000EP0765476B1 The use of sialic acid determination for determining alcohol consumption
11/22/2000CN2407012Y Disposable box for testing escherichia coli
11/22/2000CN1274421A Biosensor
11/22/2000CN1274389A Methods for DNA amplification and kits therefor
11/22/2000CN1274386A Genetic control of plant growth and develepmnt